53
Views
4
CrossRef citations to date
0
Altmetric
Reviews

An update on hybrid drugs in cardiovascular drug research

Pages 1397-1408 | Published online: 01 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Atul Bhardwaj, Jatinder Kaur, Frank Wuest & Edward E Knaus. (2014) Do nitric oxide-releasing drugs offer a potentially new paradigm for the management of cardiovascular risks in diabetes?. Expert Review of Cardiovascular Therapy 12:5, pages 533-536.
Read now

Articles from other publishers (3)

Harbinder Singh & Devendra K. Agrawal. (2022) Recent advances in the development of active hybrid molecules in the treatment of cardiovascular diseases. Bioorganic & Medicinal Chemistry 62, pages 116706.
Crossref
Atul BhardwajJatinder Kaur & Edward E Knaus. (2013) Can nitric oxide-releasing hybrid drugs alleviate adverse cardiovascular risks?. Future Medicinal Chemistry 5:4, pages 381-383.
Crossref
Alma Martelli, Lara Testai, Maria Cristina Breschi, Corrado Blandizzi, Agostino Virdis, Stefano Taddei & Vincenzo Calderone. (2010) Hydrogen sulphide: novel opportunity for drug discovery. Medicinal Research Reviews 32:6, pages 1093-1130.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.